D

Dainippon Sumitomo Pharma

219 employees

Dainippon Sumitomo Pharma is a pharmaceutical company based in Japan.

Investor insights

Sectors invested in

Health Care6
Biotechnology5
Medical3
Medical Device2
medical technology1
Stem cell1
バイオベンチャー1
iPS1
マザーズ1
MultiStem1
再生医療1
再生医薬品1
mHealth1
Biopharma1
Pharmaceutical1
Product Research1
Health Diagnostics1
Men's1
Women's1
Life Science1

Funding rounds participated in

$24M sweet spot round size

Most of their 9 investments are in rounds between $8.1M and $50M

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
Health Diagnostics
Health Care

Date founded

1984

Investments made

R

Roivant Sciences raised $200M on October 1, 2021

Investors: Suvretta Capital Management LLC, Patient Square Capital, Palantir Technologies, Viking Global Investors, Eventide Asset Management, RTW Investments, LP and Dainippon Sumitomo Pharma

M

Myovant Sciences raised $200M on August 5, 2020

Investors: Dainippon Sumitomo Pharma

D

Drawbridge Health raised undisclosed on July 24, 2019

Investors: GE Ventures and Dainippon Sumitomo Pharma

U

Undisclosed raised $8.1M on April 5, 2019

Investors: SMBCベンチャーキャピタル(株), Kyoto University Innovation Capital Co., Ltd, NVCC and Dainippon Sumitomo Pharma

株式会社メルティンMMI raised $18M on October 17, 2018

Investors: SBI Investment, The Dai-ichi Life Insurance Company, Limited and Dainippon Sumitomo Pharma

F

FunPep Co., Ltd. raised $4M on October 5, 2018

Investors: バイオ・サイト・キャピタル(株), Morishita Jintan Co Ltd, Shionogi & Co., Ltd and Dainippon Sumitomo Pharma

U

Undisclosed raised $8.3M on May 22, 2014

Investors: 日本ビーシージー製造株式会社, Innovation Network Corporation Of Japan and Dainippon Sumitomo Pharma

E

Edison Pharmaceuticals raised $50M on March 27, 2014

Investors: Dainippon Sumitomo Pharma

H

Healios K.K. raised $31M on October 8, 2013

Investors: SNBL USA, Dogan, Inc. and Dainippon Sumitomo Pharma

FAQ